Cargando…

Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]

BACKGROUND: Xylitol is a naturally occurring sugar substitute that has been shown to reduce the level of mutans streptococci in plaque and saliva and to reduce tooth decay. It has been suggested that the degree of reduction is dependent on both the amount and the frequency of xylitol consumption. Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, Kiet A, Milgrom, Peter, Roberts, Marilyn C, Yamaguchi, David K, Rothen, Marilynn, Mueller, Greg
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482697/
https://www.ncbi.nlm.nih.gov/pubmed/16556326
http://dx.doi.org/10.1186/1472-6831-6-6
_version_ 1782128290711994368
author Ly, Kiet A
Milgrom, Peter
Roberts, Marilyn C
Yamaguchi, David K
Rothen, Marilynn
Mueller, Greg
author_facet Ly, Kiet A
Milgrom, Peter
Roberts, Marilyn C
Yamaguchi, David K
Rothen, Marilynn
Mueller, Greg
author_sort Ly, Kiet A
collection PubMed
description BACKGROUND: Xylitol is a naturally occurring sugar substitute that has been shown to reduce the level of mutans streptococci in plaque and saliva and to reduce tooth decay. It has been suggested that the degree of reduction is dependent on both the amount and the frequency of xylitol consumption. For xylitol to be successfully and cost-effectively used in public health prevention strategies dosing and frequency guidelines should be established. This study determined the reduction in mutans streptococci levels in plaque and unstimulated saliva to increasing frequency of xylitol gum use at a fixed total daily dose of 10.32 g over five weeks. METHODS: Participants (n = 132) were randomized to either active groups (10.32 g xylitol/day) or a placebo control (9.828 g sorbitol and 0.7 g maltitol/day). All groups chewed 12 pieces of gum per day. The control group chewed 4 times/day and active groups chewed xylitol gum at a frequency of 2 times/day, 3 times/day, or 4 times/day. The 12 gum pieces were evenly divided into the frequency assigned to each group. Plaque and unstimulated saliva samples were taken at baseline and five-weeks and were cultured on modified Mitis Salivarius agar for mutans streptococci enumeration. RESULTS: There were no significant differences in mutans streptococci level among the groups at baseline. At five-weeks, mutans streptococci levels in plaque and unstimulated saliva showed a linear reduction with increasing frequency of xylitol chewing gum use at the constant daily dose. Although the difference observed for the group that chewed xylitol 2 times/day was consistent with the linear model, the difference was not significant. CONCLUSION: There was a linear reduction in mutans streptococci levels in plaque and saliva with increasing frequency of xylitol gum use at a constant daily dose. Reduction at a consumption frequency of 2 times per day was small and consistent with the linear-response line but was not statistically significant.
format Text
id pubmed-1482697
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14826972006-06-24 Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664] Ly, Kiet A Milgrom, Peter Roberts, Marilyn C Yamaguchi, David K Rothen, Marilynn Mueller, Greg BMC Oral Health Research Article BACKGROUND: Xylitol is a naturally occurring sugar substitute that has been shown to reduce the level of mutans streptococci in plaque and saliva and to reduce tooth decay. It has been suggested that the degree of reduction is dependent on both the amount and the frequency of xylitol consumption. For xylitol to be successfully and cost-effectively used in public health prevention strategies dosing and frequency guidelines should be established. This study determined the reduction in mutans streptococci levels in plaque and unstimulated saliva to increasing frequency of xylitol gum use at a fixed total daily dose of 10.32 g over five weeks. METHODS: Participants (n = 132) were randomized to either active groups (10.32 g xylitol/day) or a placebo control (9.828 g sorbitol and 0.7 g maltitol/day). All groups chewed 12 pieces of gum per day. The control group chewed 4 times/day and active groups chewed xylitol gum at a frequency of 2 times/day, 3 times/day, or 4 times/day. The 12 gum pieces were evenly divided into the frequency assigned to each group. Plaque and unstimulated saliva samples were taken at baseline and five-weeks and were cultured on modified Mitis Salivarius agar for mutans streptococci enumeration. RESULTS: There were no significant differences in mutans streptococci level among the groups at baseline. At five-weeks, mutans streptococci levels in plaque and unstimulated saliva showed a linear reduction with increasing frequency of xylitol chewing gum use at the constant daily dose. Although the difference observed for the group that chewed xylitol 2 times/day was consistent with the linear model, the difference was not significant. CONCLUSION: There was a linear reduction in mutans streptococci levels in plaque and saliva with increasing frequency of xylitol gum use at a constant daily dose. Reduction at a consumption frequency of 2 times per day was small and consistent with the linear-response line but was not statistically significant. BioMed Central 2006-03-24 /pmc/articles/PMC1482697/ /pubmed/16556326 http://dx.doi.org/10.1186/1472-6831-6-6 Text en Copyright © 2006 Ly et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ly, Kiet A
Milgrom, Peter
Roberts, Marilyn C
Yamaguchi, David K
Rothen, Marilynn
Mueller, Greg
Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]
title Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]
title_full Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]
title_fullStr Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]
title_full_unstemmed Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]
title_short Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]
title_sort linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [isrctn43479664]
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482697/
https://www.ncbi.nlm.nih.gov/pubmed/16556326
http://dx.doi.org/10.1186/1472-6831-6-6
work_keys_str_mv AT lykieta linearresponseofmutansstreptococcitoincreasingfrequencyofxylitolchewinggumusearandomizedcontrolledtrialisrctn43479664
AT milgrompeter linearresponseofmutansstreptococcitoincreasingfrequencyofxylitolchewinggumusearandomizedcontrolledtrialisrctn43479664
AT robertsmarilync linearresponseofmutansstreptococcitoincreasingfrequencyofxylitolchewinggumusearandomizedcontrolledtrialisrctn43479664
AT yamaguchidavidk linearresponseofmutansstreptococcitoincreasingfrequencyofxylitolchewinggumusearandomizedcontrolledtrialisrctn43479664
AT rothenmarilynn linearresponseofmutansstreptococcitoincreasingfrequencyofxylitolchewinggumusearandomizedcontrolledtrialisrctn43479664
AT muellergreg linearresponseofmutansstreptococcitoincreasingfrequencyofxylitolchewinggumusearandomizedcontrolledtrialisrctn43479664